Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Ware

Showing results (151-160 of 267) with videos related to

Pageof 27
Sort By:
Pediatric Blood & Cancer|October 21, 2011
Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical TrialPatrick T McGann, Jonathan M Flanagan, Thad A Howard, et al.
Acta Haematologica|April 28, 2026
Persistent Splenomegaly is associated with Morbidity in Tanzanian Children with Sickle Cell Anemia: Secondary Analysis of the SPHERE TrialEmmanuela E Ambrose, George Tomlinson, Patrick S Ngoya, et al.
American Journal of Hematology|July 26, 2017
Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohortsOfelia Alvarez, Kerri Nottage, Lara M Simpson, et al.
European Journal of Clinical Pharmacology|July 18, 2006
A pharmacokinetic study of paracetamol in Thai beta-thalassemia/HbE patientsJeeranut Tankanitlert, Thad A Howard, Anusorn Temsakulphong, et al.
European Journal of Haematology|May 7, 2014
Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyureaKerri A Nottage, Russell E Ware, Bryan Winter, et al.
BMC Research Notes|June 19, 2026
Hydroxyurea interferes with point-of-care creatinine testing in children with sickle cell anemiaRuth Namazzi, Robert O Opoka, Charles Ssuuna, et al.
The New England Journal of Medicine|June 25, 2020
Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan AfricaChandy C John, Robert O Opoka, Teresa S Latham, et al.
Pediatric Blood & Cancer|March 20, 2021
Implementation of near-universal hydroxyurea uptake among children with sickle cell anemia: A single-center experienceKristine Karkoska, Kevin Todd, Omar Niss, et al.
Frontiers in Molecular Biosciences|June 16, 2023
Hydroxyurea pharmacokinetics and precision dosing in low-resource settingsLuke R Smart, Mwesige Charles, Kathryn E McElhinney, et al.
Brain Imaging and Behavior|September 2, 2011
Hemodynamic responses to visual stimulation in children with sickle cell anemiaPing Zou, Kathleen J Helton, Matthew Smeltzer, et al.
Pageof 27

Showing results (151-160 of 267) with videos related to

Sort By:
Pageof 27
Pediatric Blood & Cancer|October 21, 2011
Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical TrialPatrick T McGann, Jonathan M Flanagan, Thad A Howard, et al.
Acta Haematologica|April 28, 2026
Persistent Splenomegaly is associated with Morbidity in Tanzanian Children with Sickle Cell Anemia: Secondary Analysis of the SPHERE TrialEmmanuela E Ambrose, George Tomlinson, Patrick S Ngoya, et al.
American Journal of Hematology|July 26, 2017
Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohortsOfelia Alvarez, Kerri Nottage, Lara M Simpson, et al.
European Journal of Clinical Pharmacology|July 18, 2006
A pharmacokinetic study of paracetamol in Thai beta-thalassemia/HbE patientsJeeranut Tankanitlert, Thad A Howard, Anusorn Temsakulphong, et al.
European Journal of Haematology|May 7, 2014
Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyureaKerri A Nottage, Russell E Ware, Bryan Winter, et al.
BMC Research Notes|June 19, 2026
Hydroxyurea interferes with point-of-care creatinine testing in children with sickle cell anemiaRuth Namazzi, Robert O Opoka, Charles Ssuuna, et al.
The New England Journal of Medicine|June 25, 2020
Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan AfricaChandy C John, Robert O Opoka, Teresa S Latham, et al.
Pediatric Blood & Cancer|March 20, 2021
Implementation of near-universal hydroxyurea uptake among children with sickle cell anemia: A single-center experienceKristine Karkoska, Kevin Todd, Omar Niss, et al.
Frontiers in Molecular Biosciences|June 16, 2023
Hydroxyurea pharmacokinetics and precision dosing in low-resource settingsLuke R Smart, Mwesige Charles, Kathryn E McElhinney, et al.
Brain Imaging and Behavior|September 2, 2011
Hemodynamic responses to visual stimulation in children with sickle cell anemiaPing Zou, Kathleen J Helton, Matthew Smeltzer, et al.
Pageof 27